Details for Patent: 11,241,382
✉ Email this page to a colleague
Which drugs does patent 11,241,382 protect, and when does it expire?
Patent 11,241,382 protects TIROSINT-SOL and is included in one NDA.
This patent has eight patent family members in seven countries.
Summary for Patent: 11,241,382
Title: | Administration regimen of compositions of T4 thyroid hormone with high oral absorption |
Abstract: | New administration regimens of the T4 thyroid hormone are described, characterized by the use of alcohol-free, water-glycerol solutions of said hormone, administered at short temporal distance, i.e. within less than 30 minutes, typically between 15 and less than 30 minutes, from the closest consumed meal. |
Inventor(s): | Fossati Tiziano, Mautone Giuseppe, Scarsi Claudia |
Assignee: | ALTERGON SA |
Application Number: | US16421373 |
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 11,241,382
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-001 | Dec 15, 2016 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF HYPOTHYROIDISM BY ORAL ADMINISTRATION OF L-THYROXINE TO A PATIENT ON AN EMPTY STOMACH 15 MINUTES BEFORE BREAKFAST | ⤷ Try a Trial | ||||
Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-001 | Dec 15, 2016 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF PITUITARY THYROTROPIN SUPPRESSION BY ORAL ADMINISTRATION OF L-THYROXINE TO A PATIENT ON AN EMPTY STOMACH 15 MINUTES BEFORE BREAKFAST | ⤷ Try a Trial | ||||
Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-002 | Dec 15, 2016 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF PITUITARY THYROTROPIN SUPPRESSION BY ORAL ADMINISTRATION OF L-THYROXINE TO A PATIENT ON AN EMPTY STOMACH 15 MINUTES BEFORE BREAKFAST | ⤷ Try a Trial | ||||
Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-002 | Dec 15, 2016 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF HYPOTHYROIDISM BY ORAL ADMINISTRATION OF L-THYROXINE TO A PATIENT ON AN EMPTY STOMACH 15 MINUTES BEFORE BREAKFAST | ⤷ Try a Trial | ||||
Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-013 | Jan 13, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF PITUITARY THYROTROPIN SUPPRESSION BY ORAL ADMINISTRATION OF L-THYROXINE TO A PATIENT ON AN EMPTY STOMACH 15 MINUTES BEFORE BREAKFAST | ⤷ Try a Trial | ||||
Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-013 | Jan 13, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF HYPOTHYROIDISM BY ORAL ADMINISTRATION OF L-THYROXINE TO A PATIENT ON AN EMPTY STOMACH 15 MINUTES BEFORE BREAKFAST | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,241,382
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 3129627 | ⤷ Try a Trial | |||
China | 113645966 | ⤷ Try a Trial | |||
Denmark | 3930703 | ⤷ Try a Trial | |||
European Patent Office | 3930703 | ⤷ Try a Trial | |||
European Patent Office | 4321214 | ⤷ Try a Trial | |||
Italy | 201900003013 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |